2264.9000 -6.00 (-0.26%)
NSE Jul 07, 2026 15:31 PM
Volume: 770.7K
 

Geojit BNP Paribas
*over or under performance to benchmark index Glenmark Pharmaceuticals Ltd, which has a presence in over 80 countries, focuses on the generics, specialty and over-the-counter (OTC) segments, with a strong presence in diabetes, cardiovascular and oral contraceptives. In Q4FY26, Glenmark's normalized revenue grew 11.1% YoY to Rs. 3,616cr, driven...
FundsIndia released a Buy report for Glenmark Pharmaceuticals Ltd. with a price target of 2604.0 on 06 Jul, 2026.
More from Glenmark Pharmace…
All earning calls
Investor presentations from Glenmark Pharmace…
All investor presentations